Mirae Asset Global Investments’s Lifecore Biomedical LFCR Stock Holding History

Mirae Asset Global Investments’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.81K	Sell	1,678 -276	-14%	-$1.39K	﹤0.01%	1584
2026 Q1	$7.27K	Buy	1,954 +133	+7%	+$918	﹤0.01%	1517
2025 Q4	$14.9K	Buy	+1,821	New	+$13.5K	﹤0.01%	1573
2024 Q2	–	Sell	-10,860	Closed	-$36.1K	–	2078
2024 Q1	$36.1K	Buy	+10,860	New	+$77.7K	﹤0.01%	2431
2023 Q2	–	Sell	-10,860	Closed	-$41K	–	2656
2023 Q1	$41K	Hold	10,860	–	–	﹤0.01%	2517
2022 Q4	$70.4K	Hold	10,860	–	–	﹤0.01%	2498
2022 Q3	$97K	Buy	+10,860	New	+$110K	﹤0.01%	2508

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Mirae Asset Global Investments's LFCR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Lifecore Biomedical (LFCR) stake by 14% in Q2 2026, selling an estimated $1.39K and leaving 1,678 shares worth $8.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

Mirae Asset Global Investments first reported a position in LFCR in Q3 2022 and has held it in 7 quarters since. The position peaked at $97K in Q3 2022. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

Mirae Asset Global Investments held 1,678 shares of Lifecore Biomedical worth $8.81K as of Q2 2026.
Mirae Asset Global Investments sold 276 Lifecore Biomedical shares in Q2 2026, an estimated $1.39K.
Lifecore Biomedical made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1584 holding.
Mirae Asset Global Investments first reported a position in Lifecore Biomedical in Q3 2022 and has held it in 7 quarters since.
Mirae Asset Global Investments's Lifecore Biomedical position peaked at $97K in Q3 2022.
98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.